Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIENCY) EQUITY

v3.24.1.1.u2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIENCY) EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Treasury Stock
Total
Balance at Mar. 31, 2021 $ 13 $ 934,381 $ (930,213) $ (1,949) $ 2,232
Balance (in shares) at Mar. 31, 2021 12,898,144        
Balance, treasury stock (in shares) at Mar. 31, 2021       73,954  
Increase (Decrease) in Stockholders' Equity          
Purchase of treasury stock       $ (139) (139)
Purchase of treasury stock (in shares)       27,679  
Vested restricted stock awards   100     100
Vested restricted stock awards (in shares) 124,184        
Stock-based compensation   1,245     1,245
Stock awards to Board of Directors (in shares) 70,260        
Issuance of common stock, net of issuance costs $ 2 11,243     11,245
Issuance of common stock, net of issuance costs (in shares) 2,305,780        
Net loss     (22,370)   (22,370)
Balance at Mar. 31, 2022 $ 15 946,969 (952,583) $ (2,088) $ (7,687)
Balance (in shares) at Mar. 31, 2022 15,398,368       15,398,368
Balance, treasury stock (in shares) at Mar. 31, 2022       101,633 101,633
Increase (Decrease) in Stockholders' Equity          
Net loss         $ (4,200)
Balance at Jun. 30, 2022         (11,655)
Balance at Mar. 31, 2022 $ 15 946,969 (952,583) $ (2,088) $ (7,687)
Balance (in shares) at Mar. 31, 2022 15,398,368       15,398,368
Balance, treasury stock (in shares) at Mar. 31, 2022       101,633 101,633
Increase (Decrease) in Stockholders' Equity          
Net loss         $ (7,853)
Balance at Sep. 30, 2022         (7,904)
Balance at Mar. 31, 2022 $ 15 946,969 (952,583) $ (2,088) $ (7,687)
Balance (in shares) at Mar. 31, 2022 15,398,368       15,398,368
Balance, treasury stock (in shares) at Mar. 31, 2022       101,633 101,633
Increase (Decrease) in Stockholders' Equity          
Net loss         $ (14,189)
Balance at Dec. 31, 2022         (14,008)
Balance at Mar. 31, 2022 $ 15 946,969 (952,583) $ (2,088) $ (7,687)
Balance (in shares) at Mar. 31, 2022 15,398,368       15,398,368
Balance, treasury stock (in shares) at Mar. 31, 2022       101,633 101,633
Increase (Decrease) in Stockholders' Equity          
Purchase of treasury stock       $ (51) $ (51)
Purchase of treasury stock (in shares)       15,381  
Vested restricted stock awards   52     52
Vested restricted stock awards (in shares) 124,104        
Stock-based compensation   863     863
Stock awards to Board of Directors (in shares) 54,585        
Issuance of common stock, net of issuance costs $ 3 7,247     7,250
Issuance of common stock, net of issuance costs (in shares) 2,934,498        
Deemed dividend on purchase warrant for common shares   97 (97)    
Net loss     (24,522)   (24,522)
Balance at Mar. 31, 2023 $ 18 $ 955,228 $ (977,202) $ (2,139) $ (24,095)
Balance (in shares) at Mar. 31, 2023 18,511,555       18,511,555
Balance, treasury stock (in shares) at Mar. 31, 2023       117,014 117,014
Balance at Jun. 30, 2022         $ (11,655)
Increase (Decrease) in Stockholders' Equity          
Net loss         (3,653)
Balance at Sep. 30, 2022         (7,904)
Increase (Decrease) in Stockholders' Equity          
Net loss         (6,336)
Balance at Dec. 31, 2022         $ (14,008)